On this page

Ajovy

fremanezumab-vfrm

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Ajovy
Proper name
fremanezumab-vfrm
Licence type
351(a)
BLA number
761089
Applicant
Teva Branded Pharmaceutical Products R&D, Inc.
Center
CDER
Presentations
2
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
225MG/1.5ML Injection Subcutaneous Pre-Filled Syringe Rx September 14, 2018
225MG/1.5ML Injection Subcutaneous Autoinjector Rx January 27, 2020

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity